healthcare

CDC update requires 6 questions for all new COVID-19 test patients

CDC update requires 6 questions for all new COVID-19 test patients

This week, an updated set of questions were released by the CDC for COVID-19 laboratory test orders. Anyone who orders a COVID-19 test, collects a specimen, or performs a laboratory test, "must make every reasonable effort to collect complete demographic information as well as responses to the following 'ask on order entry' (AOE) questions." These AOE questions were updated as of January 18, 2020 by the CDC.

Continue Reading

CDC chief issues blunt update on uncounted COVID-19 cases

CDC chief issues blunt update on uncounted COVID-19 cases

COVID-19 could have been ten times more prevalent than previously believed, the CDC director has suggested, with new testing indicating the coronavirus pandemic had been far more expansive than assumed. The US Centers for Disease Control has been assessing antibody test results from March through May 2020, with the agency's findings casting COVID-19 case numbers into new light.

Continue Reading

Oxford COVID-19 vaccine hits key immune response milestone

Oxford COVID-19 vaccine hits key immune response milestone

A COVID-19 vaccine is already showing important successes on the road to potential immunization against coronavirus, with Oxford University claiming another milestone for the work-in-progress drug. The possible vaccine is one of several in development around the world, as private companies and research labs alike hunt for a way to address the ongoing pandemic.

Continue Reading

COVID-19 vaccine candidates: Key ones to follow

COVID-19 vaccine candidates: Key ones to follow

COVID-19 cases continue to rise in many countries suggesting clearly that the pandemic is showing no signs of slowing down. The virus remains the number one human enemy with the sole intention of finding people to infect. The only way to remain safe from the virus is to break chains of transmission by following public health principles of social distancing, washing hands frequently, wearing masks in public, and staying home when sick.

Continue Reading

Google’s big bet that virtual work is “here to stay”

Google’s big bet that virtual work is “here to stay”

Google's gone ahead and put their efforts to bring a massive update to work-at-home tools into hyperspace. They're packaging the tools as a sort of upgrade to G Suite, but we know better. Given the message this set of changes is delivered with, it's clear Google's prepared itself for what they see as the inevitable. This post-workplace work from home world brought on by COVID-19 and global pandemic isn't just a temporary change - it's the way of the future!

Continue Reading

The CDC director just dropped a bombshell on COVID-19 mask-wearing

The CDC director just dropped a bombshell on COVID-19 mask-wearing

As little as 1-2 months of consistent mask-wearing across the US could be enough to tame COVID-19, the CDC chief has predicted, highlighting the stakes at play as the coronavirus pandemic looks set to surge again. Cases of infection had been dropping across America as states enacted lockdowns, but efforts to reopen businesses have threatened to upend that progress.

Continue Reading

Bubonic plague squirrel found in Colorado

Bubonic plague squirrel found in Colorado

A squirrel tested positive for bubonic plague in Morrison, Colorado over the weekend. This is the first confirmed case of plague in the county (Jefferson County, Colorado), but not the first case of plague in the state. The report appeared on Saturday, July 11, 2020, when the Jefferson County Colorado Public Health department delivered results to the community with a set of symptoms and warning signs.

Continue Reading

Equillium COVID-19 clinical trial shows “significantly reduced mortality”

Equillium COVID-19 clinical trial shows “significantly reduced mortality”

Today the company Equillium reported that clinical trials of their drug itoizamub "significantly reduced mortality" in patients with COVID-19. Equillium is a clinical-stage biotechnology company whose focus is largely COVID-19-related - like many companies of this sort at the moment. They reported today that a Biocon, India clinical trial with itolizumab "significantly reduced mortality in patients hospitalized with COVID-19."

Continue Reading

The FDA says these hand sanitizers could kill you

The FDA says these hand sanitizers could kill you

The US Food and Drug Administration has released a list of potentially fatal hand sanitizers, which if used could be toxic or worse. The COVID-19 crisis saw a rush on alcohol hand rub supplies, clearing store shelves as worried shoppers tried to find a backup for when traditional hand-washing with soap and water wasn't available.

Continue Reading

COVID-19 vaccine rules see FDA try to win over anti-vaxxers

COVID-19 vaccine rules see FDA try to win over anti-vaxxers

Fearing skepticism or even outright refusal among some Americans to consider a COVID-19 vaccination, the US Food and Drug Administration has preemptively published its guidelines for the development of a lasting coronavirus treatment. The recommendations, released today, cover the process by which the FDA will eventually approve potential COVID-19 vaccines, at least in part to try to bring "anti-vaxx" advocates onboard.

Continue Reading

Polar Unite smart fitness watch will cost you around $150

Polar Unite smart fitness watch will cost you around $150

The smart fitness watch Polar Unite was revealed today with an essential set of features that allow it to be priced at approximately $150. This same brand has a device called Polar Grit X that goes all-out on features for approximately 430-Euro, down to the Polar Ignite, a device that'll cost just under 200-Euro. They've also got a Fitness Tracker device called Polar A370 that'll run you around $170-Euro - and the Polar M200, a "GPS Running Watch" that costs almost exactly the same amount of cash as the Polar Unite.

Continue Reading

Gilead CEO answers big COVID-19 question: How much will remdesivir cost

Gilead CEO answers big COVID-19 question: How much will remdesivir cost

Gilead Sciences has addressed the big question surrounding just how much its drug remdesivir will cost for COVID-19 treatment, after positive early trials indicated the medicine could hasten recovery during the pandemic. The announcement will come as a disappointment to anybody hoping coronavirus treatment might be given free of charge, though Gilead argues that it's pricing remdesivir aggressively.

Continue Reading

Prev 1 2 3 4 5 Next